Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.
| Last: | $0.9372 |
|---|---|
| Change Percent: | 10.62% |
| Open: | $0.904 |
| Close: | $0.8472 |
| High: | $0.97 |
| Low: | $0.9 |
| Volume: | 612,510 |
| Last Trade Date Time: | 03/10/2026 12:43:59 pm |
| Market Cap: | $86,228,238 |
|---|---|
| Float: | 94,145,558 |
| Insiders Ownership: | 1.44% |
| Institutions: | 38 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.atyrpharma.com |
| Country: | US |
| City: | San Diego |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about aTyr Pharma Inc. (NASDAQ: ATYR).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
